PALO ALTO, Calif.- March 27, 2025 — Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents for patient-facing non-diagnostic clinical tasks, today announced the addition of Chris Fang, MD, Hollie Vugrinovich, Jonathan Gainor, W.B. “Mitch” Mitchell, Brij Aswani, Chitra Laxmanan, and Eric Seastedt to its executive leadership team. These leaders will accelerate the company’s growth into new market segments and international regions, advancing Hippocratic AI’s mission to deliver global healthcare abundance and improved patient outcomes.
These hires follow the company’s successful $141 million Series B financing round and the overwhelmingly positive response to its generative AI healthcare agents. The company recently unveiled Polaris 3.0, its safest and most advanced constellation architecture yet, incorporating extensive real-world insights gathered directly from patients and healthcare providers. With more than 1.85 million patient calls and 25+ healthcare enterprise partners, Polaris 3.0 has set a new standard in patient safety and satisfaction, achieving a clinical accuracy rate of 99.38% and a new high patient rating of 8.95/10.
“We have always thought that Hippocratic AI could benefit all sectors of healthcare worldwide and the tremendous success of the launch of our GenAI agents among North American healthcare providers, clinicians, and patients is a strong indicator that we are on that path. Chris Fang, Hollie Vugrinovich, Jonathan Gainor, Mitch Mitchell, Brij Aswani Chitra Laxmanan, and Eric Seastedt bring a wealth of experience, credibility, and connections relating to the successful introduction and integration of transformational technologies into healthcare and have pivotal roles in making our quest to make healthcare abundance a reality.”
Munjal Shah, Co-founder and Chief Executive Officer.
Chris Fang’s roles are to establish Hippocratic AI as a leader in AI-powered patient engagement and clinical trials by integrating AI agents into existing workflows and operations of Pharma/Life Sciences companies and to expand its customer base internationally to bridge the healthcare workforce gap and support global public health. He joined Hippocratic AI from Sidekick Health, a digital health and therapeutics company, where he was the President of Pharma and Chief Medical Officer. Before that, he held executive positions at Eli Lilly, IQVIA, Acer, and Johnson & Johnson, among others. He has an MBA from the University of Pennsylvania, an MD from Cornell University, an M.H. Sc in Public Health from Johns Hopkins, and a BA from UCLA. “I joined Hippocratic AI because I see a once-in-a-generation opportunity to transform patient engagement in pharma and life sciences. AI-powered voice agents can scale empathetic, compliant, and effective interactions,” said Chris Fang. “This technology isn’t just about AI; it’s about improving patient outcomes, and that’s why I’m here.”